baber/WOPTO huggingface dataset:
Patent GR-3020250-T3 (GR)
Title: Process and apparatus for removal of H2S with separate absorber, and oxidizer and a reaction chamber therebetween
Inventor: HARDISON LESLIE C
IPC: B01J10/00
Filed: 1996-06-18
Abstract: A method and apparatus including a reaction chamber interposed in a polyvalent metal redox solution flow path between an absorber chamber and an oxygenation chamber, including one or more oxygenation stages, for contact in the reaction chamber of H2S-laden catalytic polyvalent metal redox solution form the absorber chamber with highly oxidized polyvalent metal redox solution from the last oxygenation stage to accomplish oxidation of the dissolved H2S species by interaction with the oxidized redox catalyst essentially in the absence of gaseous dissolved oxygen. The highly oxidized polyvalent metal redox solution, including Fe<+><3> or V<+><5>, contacts the H2S-laden solution from the absorber chamber for reoxidation of the dissolved HS<->, S<=> and any of the polyvalent metal sulfur compounds (presumably a chelated iron sulfide or a vanadium sulfide), to avoid formation of sulfate or thiosulfate salts which reduce the yield of sulfur and build up in the solution. To avoid the formation of crystals of iron sulfide or crystals of vanadium sulfide, thereby avoiding loss of polyvalent metal, the residence time of the redox solution after contact with the H2S-containing gas and prior to contacting with the oxidized metal redox soluton is limited to a relatively short time. Flow of solution from the last oxygenation stage, preferably through a valve or other circulation control device, to the reaction chamber provides controlled and continuous elemental sulfur formation in the reaction chamber. <IMAGE>
Patent GR-3023723-T3 (GR)
Title: Method of activating cytolytic activity of lymphocytes using anti-CD28 antibody
Inventor: LEDBETTER JEFFERY A
IPC: A61K35/14
Filed: 1997-06-11
Abstract: The development of cytolytic activity of lymphocytes can be potentiated by contacting the lymphocytes with antibody reactive with CD28 receptor, such as 9.3 monoclonal antibody. The cytolytic activity thus potentiated is CD3 heteroconjugate-independent since targeting with a CD3 anti-target compound is not required. The development of cytolytic activity can be further potentiated by also contacting the lymphocytes with antibody reactive with anti-CD2 antibody or immobilized antibody to the CD3 receptor, or by also contacting the lymphocytes with interleukin-2. The CD28 receptor may be aggregated on the surface of the lymphocytes, as by crosslinking the antibody reactive to it on the surface of the lymphocytes. This crosslinking can be by the use of a second antibody reactive with the anti-CD28 antibody. Another aspect of the present invention is a method of adoptive therapy for treating cancer in a subject comprising the steps of: (1) contacting lymphocytes in vitro with an antibody reactive with CD28 receptor to potentiate the development of cytolytic activity of the lymphocytes to produce lymphocytes having cytolytic activity that is CD3 heteroconjugate independent; and (2) introducing the cytolytic lymphocytes into a subject to kill cancer cells.
Patent GR-3024095-T3 (GR)
Title: Bile-acid derivatives, a process for their production and their use as medicines
Inventor: KRAMER WERNER DR
IPC: A61K31/58
Filed: 1997-07-15
Abstract: Bile acid derivatives of the formula I  W-X-G in which G is a bile acid residue, W is an active substance portion of a medicament and X is a linker between bile acid residue and active substance portion, are outstandingly suitable for introducing active substances into the enterohepatic circulation. The compounds I are absorbed and enter the bloodstream. This makes it possible by utilising the natural reabsorption of the bile acids to improve the absorption of drugs which are absorbed with difficulty, if at all. W can be, for example, a peptide, an antibiotic, an antiviral substance, an anticancer agent, a liver protective, an antihyperlipidaemic, a diuretic, an agent to lower blood pressure, a renin inhibitor, a substance to treat cirrhosis of the liver or a substance for treating diabetes. G is a bile acid residue in the form of the free, natural or chemically modified acids, the esters and amides, the salt forms and forms derivatised on alcohol groups. X is a large number of intermediate members or else a bond.
Patent GR-3024223-T3 (GR)
Title: Xylanase, xylanase-producing bacillus and applications thereof
Inventor: SAMAIN ERIC
IPC: D21C9/10
Filed: 1997-07-23
Abstract: A xylanase has a molecular weight of approximately 22 kDA, an isoelectric point of approximately 7.7, is stable at 60 C and has an optimal activity pH of between 4.8 and 7. Said xylanase is secreted by bacillus strains and can be purified by concentrating the supernatant found on the culture of these strains, passage through an ion exchange column and then a hydrophobic interaction column. The xylanase obtained can be used in for bleaching paper pulp and for the preparation of xylo-oligosaccharides from vegetal raw materials.
Patent GR-3024775-T3 (GR)
Title: Photostable sunscreen compositions.
Inventor: DECKNER GEORGE ENDEL
IPC: A61Q17/04
Filed: 1997-09-25
Abstract: The present invention relates to sunscreen compositions having improved photostability, especially in the UVA region, along with providing broad coverage in both the UVA and UVB regions. These compositions are achieved by combining a UVA-absorbing dibenzoylmethane sunscreen with a UVB-absorbing benzylidene camphor sunscreen. In highly preferred embodiments, these compositions also contain from about 0.1% to about 25% of an inorganic physical sunblock. These compositions are useful for protecting the skin from the harmful effects of ultraviolet radiation and for moisturizing the skin.
Patent GR-3026193-T3 (GR)
Title: Compositions for deodorising animal excreta, and deodorising method therefor
Inventor: BASSET JACQUES
IPC: A61L11/00
Filed: 1998-02-23
Abstract: PCT No. PCT/FR94/00755 Sec. 371 Date May 15, 1996 Sec. 102(e) Date May 15, 1996 PCT Filed Jun. 22, 1994 PCT Pub. No. WO95/00182 PCT Pub. Date Jan. 5, 1995This composition for deodorizing animal faeces such as liquid manure, in particular liquid pig manure, is characterized in that it comprises: (a) at least one normal superphosphate; (b) at least one compound chosen from undecylenic acid, its esters and its polyoxyalkyle-mated esters; and optionally (c) sodium perborate. The constituent (a) is in particular a normal superphosphate containing approximately 16-18% by weight of P2O5. The constituent (b) is in particular methyl undecylenate. The composition is formulated, for example, order to be able to treat animal faeces with up to approximately 10,000 ppm of the constituent (a); up to approximately 1000 ppm of the constituent (b); and up to approximately 500 ppm of active O2 form the constituent (c), these amounts being calculated with respect to the weight of the animal faeces to be treated.
Patent GR-3032740-T3 (GR)
Title: Detection of antibody production
Inventor: HAAHEIM LARS REINHARDT
IPC: G01N33/569
Filed: 2000-02-23
Abstract: PCT No. PCT/GB96/00392 Sec. 371 Date Aug. 21, 1997 Sec. 102(e) Date Aug. 21, 1997 PCT Filed Feb. 21, 1996 PCT Pub. No. WO96/26443 PCT Pub. Date Aug. 29, 1996The present invention provides a method of detecting active antibody production in a blood sample by contacting, in the presence and absence of protein synthesis inhibitor, aliquots of the sample with a solid phase under conditions which permit antibody production and secretion by the lymphocytes; detecting in solution, binding of antibody to the antigen(s) on the solid phase; and comparing the antibody binding in the presence or absence of protein synthesis inhibitor, whereby to obtain a determination of the amount of active antibody secretion in response to the antigen(s); and kits for performing the method. The method may also be modified to allow detection of non-specific infection indicators.
Patent GR-3033876-T3 (GR)
Title: Integrated optical polarization manipulating device.
Inventor: VAN DER TOL JOHANNES JACOBUS G
IPC: G02B6/34
Filed: 2000-07-03
Abstract: An integrated optical, polarization-manipulating device, comprises a first waveguiding section (A) with a first guide (21), a second waveguiding section (E) with a second and a third optically decoupled and physically separated guide (26, 27) and an intermediary waveguiding section (C) for an adiabatic coupling between the first and the second sections (A, B). The intermediary section (C) comprises a polarization-sensitive asymmetric Y-branching device, provided with two mutually diverging intermediary guides (24, 25), a monomodal (24) and a bimodal (25), coupled to the guides (26, 27), respectively, of the second section. The guides (21, 27) form, with dummy guides (22, 28), respectively, polarization-insensitive asymmetric Y-junctions which function as mode converters between zeroth- and first-order guided modes. Bimodal coupling sections (B, D) provide for adiabatic couplings between asymmetric Y-junctions and the intermediary section (C). Advantages: the device can be provided on non-birefringent materials; is relatively simple to manufacture; and, in the case of the ridge-type guide structure, only one etching step is required. <IMAGE>
Patent GR-3035479-T3 (GR)
Title: Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines.
Inventor: WEIDMANN KLAUS DR
IPC: A61K31/4418
Filed: 2001-02-28
Abstract: The invention relates to sulphonamido- and sulphonamidocarbonyl-pyridine-2-carboxamides of the general formula I   <IMAGE> and their use as medicines, in particular against fibrotic disorders.
Patent GR-3035791-T3 (GR)
Title: Method for preparing organic disulphides and polysulphides
Inventor: ARRETZ EMMANUEL
IPC: B01J31/06
Filed: 2001-04-27
Abstract: The preparation of organic disulphides and polysulphides by reaction of sulphur with a mercaptan or with a polysulphide of lower sulphur order in order to convert it into polysulphide of higher order, or alternatively by reaction of a mercaptan with an organic polysulphide of high sulphur order in order to convert it into polysulphide of lower sulphur order, in the presence of a catalyst in the form of a resin with a basic function, characterized in that the resin is based on polystyrene-divinylbenzene (PS-DVB) functionalized with primary amino groups and having the general formula (I):    <IMAGE>  (I)    <IMAGE>   being the PS-DVB resin support, L being a linear organic radical which is as long as or longer than the methylene radical (-CH2-).
Patent GR-3036092-T3 (GR)
Title: Broad spectrum antimicrobial compounds and methods of use
Inventor: SELSTED MICHAEL E
IPC: A61P31/04
Filed: 2001-06-20
Abstract: The present invention provides indolicidin analogs, which are tryptophan-rich peptides that have substantially the same amino acid sequence as naturally occurring indolicidin, exhibit broad spectrum antimicrobial activity and have antimicrobial selectivity as compared to naturally occurring indolicidin. The invention also provides methods of using an indolicidin analog to inhibit or prevent the survival or growth of a microorganism in an environment capable of sustaining such survival or growth. The invention provides, for example, methods of administering an effective amount of an indolicidin analog to an environment capable of sustaining the survival or growth of a microorganism.
Patent GR-3036634-T3 (GR)
Title: Novel protein polycation conjugates.
Inventor: BIRNSTIEL MAX L
IPC: A61K47/48
Filed: 2001-09-17
Abstract: New protein-polycation conjugates which are capable of forming soluble complexes with nucleic acids contain as their protein component an antibody directed against a cell surface protein, with the ability to bind to the cell surface protein so that the complexes formed are absorbed into cells which express the cell surface protein and are expressed therein. Complexes for use in pharmaceutical preparations contain a therapeutically or gene therapeutically active nucleic acid.
Patent DK-0973635-T4 (DK)
Inventor: CHRISTEN ANDREAS
IPC: B29C45/27
Filed: 1999-01-19
Granted: 2006-12-11
Abstract: A dynamic molten mass guide sleeve disposed to articulate to compensate for differences in expansion between an inner hot flow hot channel injection and mold cavity with air gap insulation therebetween. Prior fixed molten mass guide sleeves required extremely stringent location deviations and often led to mold cavity ruptures or leakage as a result of differential expansion between the nozzle body having the hot flow channel and the mold cavity channel. The inventive sleeve is fitted with peripheral sealing lips at each end and is mounted between the body having the hot flow channel and the mold cavity (6). The sleeve compensates for differential heat expansion while enabling well-defined temperature separation in the mold feed orifice area of the injection mold by sealing the air gap (4).
Patent TR-200402712-T4 (TR)
Title: Kalsiyum nitrat granülleri üretim yöntemi
Inventor: RABIE DIRK RENIER HENDRIK
IPC: C01F/
Filed: 2001-05-02
Abstract: Bu bulus bir kalsiyum nitrat granülleri üretim yöntemi ile ilgilidir. Bir kalsiyum nitrat eriyigi  bir birinci akiskanli yatakli granüllestiricinin bir tekrar-sirkülasyon yatagina spreylenir, burada tekrar-sirkülasyon  yatagi nemi alinmis ve 60 C ila 100 C arasinda bir sicakliga isitilmis hava ile beslenir. Granüllestirici içinde olusturulan kalsiyum nitrat granüller,bir ikinci akiskanli yatak formundaki bir birinci sogutucuya verilir, burada granüller nemi alinmis hava ile 50 C ila 60 C'ye sogutulur. Granüller bir ayirici içinde ayrilir ve daha sonra çuvallara doldurulmadan önce, bir ikinci sogutucu içinde 40  C den daha düsük bir sicakliga sogutulur.Bu sekilde üretilen granüller sert ve kurudur ve kotarilmalari sirasinda kolaylikla kirilmaz.
Patent TR-201809413-T4 (TR)
Title: Self-protein cldn18.2 ye karşı bir humoral immün yanıtı içeren tümor aşılama.
Inventor: THORSTEN KLAMP
IPC: C12N7/00
Filed: 2011-03-09
Abstract: Mevcut buluş, bir tümörle ilişkili antijenin hücre dışı bölümünden türetilen bir epitop içeren bir amino asit dizisi ve bir hepatit B virüsü çekirdek antijen proteininin tamamını veya bir bölümünü içeren kimerik proteinleri kullanarak tümör immünoterapisi, özellikle tümör aşılaması ile ilgilidir. Özellikle, mevcut buluş, bahsedilen kimerik proteinleri içeren virüs benzeri parçacıklar sağlar; bunlar, bir hastada tümörle ilişkili antijene karşı, özellikle de yüzeyinde bahsedilen tümör-ilişkili antijeni taşıyan hücrelere karşı bir humoral immün yanıtını ortaya çıkarmak için yararlıdır; burada tümörle ilişkili antijen, bahsedilen hastada bir self-proteindir.
Patent TR-201900273-T4 (TR)
Title: İnhaler.
Inventor: ALEX HEARN
IPC: A24F42/60
Filed: 2013-08-27
Abstract: İnhale edilebilir bir bileşimin rezervuarını (2) içeren aşağıdakileri içeren bir inhalerdir, Esnek bir diyafram (14) ile hareket ettirilen ve bir rezervuardan bir bileşim akış yolunu kapattığı bir konuma eğilen bir valf elemanıdır (11). Bir birinci hava çıkış yolu (16) kısmen diyaframın bir tarafı ile belirlenir ve bir ikinci hava çıkış yolu (17) kısmen diyaframın karşıt tarafı ile belirlenir. Her çıkış yolu, bir çıkış ucunda bir çıkış açıklığı (19, 21) içerir ve ikinci akış yolu çıkış ucundan akış yukarı bir giriş (20) içerir. Hava akış yolları (16, 17), çıkış ucundaki çekiş, birinci hava akış yolundaki basınçta ikinci hava akış yolundaki basınca göre bir azalmaya neden olacak şekilde düzenlenir, diyaframı hareket ettiren ve dolayısıyla bileşim akış yolunu açmak üzere eğme kuvveti karşısında valf elemanını (11) hareket ettiren diyafram (14) karşısında bir basınç farkı oluşturur.
Patent TR-201900519-T4 (TR)
Title: Kauçuk ve plastik içeren hortum.
Inventor: AARON DAVID CLARK
IPC: B29K105/08
Filed: 2014-09-15
Abstract: Bir ara yapıştırıcı katmanı olmadan bir kesintisiz poliamid katmanına doğrudan bağlı bir kauçuk destek katmanı içeren bir hortum sağlanmaktadır, burada hortum standart otomotiv soğutucu madde hortumlarına kıyasla arttırılmış düşük ve yüksek sıcaklık özelliği ve azaltılmış geçirgenlik sergiler.
Patent TR-201903245-T4 (TR)
Title: Bir sıvı metalin ultrasonla kontrol prosesi.
Inventor: JEAN-LOUIS ACHARD
IPC: G01N29/22
Filed: 2015-10-06
Abstract: Proses aşağıda sayılan adımları içermektedir: a) Örneğin seramik gibi sıvı metale karşı esasen inert olan bir malzemeden ve tercihen, örneğin SIALON gibi silisyum nitrür veya silisyum oksinitrürden ya da söz konusu sıvı metale karşı esasen inert olan bir metalden oluşturulan bir sonotrot (1) sunmak, b) Söz konusu metalin bir banyosuna sonotrotu (1) en azından kısmen daldırmak, c) Sonotrotu söz konusu metalle ıslatmak amacıyla güç ultrasonlarını, özellikle de 10 watt'tan daha güçlü ultrasonları söz konusu sonotrota (1) uygulamak, d) Aynı zamanda kontrol ultrasonları olarak da anılan ölçüm ultrasonlarını, özellikle de 1 ile 25 MHz arasında bir frekansa sahip ultrasonları kesintisiz bir biçimde sonotrota (1) uygulamak, e) Söz konusu ıslatma işleminin neticesini muhafaza etmek ve sinyalin zaman içindeki stabilitesini garanti altına almak amaçlarıyla, güç ultrasonlarını, özellikle de 10 watt'tan daha güçlü ultrasonları sonotrota (1) kesintili olarak uygulamak.
Patent TR-201903470-T4 (TR)
Title: Kişisel hijyen için formülasyon.
Inventor: GIORGIO PANIN
IPC: A61K8/67
Filed: 2015-03-20
Abstract: Bu buluş kozmetik ve farmasötik endüstri alanı ile ilgilidir. Özellikle buluş, dış genital organların hastalığı ve inflamatuvarı durumlarında, belirgin dayanma gücü özellikleriyle sağlanmış ve yatıştırıcı özellikleri ile bir destekleyici olarak kullanıma uygun olan kişisel hijyen için olan bir formülasyon ile ilgilidir. Bu buluşun temelindeki problem bilenen formülasyonlardan daha yüksek bir dayanma gücüne sahip olan ve etkin bir yatıştırıcı ve antimikrobiyal etkiyi gerçekleştirirken, iritasyon veya diğer problemlere neden olmadan dış genital mukoza zar hastalıklı kişilerce bile kullanılabilen yeni bir kişisel hijyen formülasyonu sağlamaktır. Böyle bir problem 14 ila 22 karbon atomlu bir yağ alkolünden veya gliseril monostearattan (INCI adı: Gliseril Stearat) veya bunların bir karışımından oluşan bir emülgatörü içeren hariç olmak üzere, 5.5 ila 6.5 arasındaki bir pH ile O/W emülsiyonu biçiminde kişisel hijyen için bir formülasyon sağlayarak çözülmüştür, bu formülasyon ayrıca Koko Kaprilat ve/veya Koko Kaprilat/kaprat, vitamin E veya formülasyonun toplam ağırlığının ağırlıkça % 2.0 ila 15 miktarında bunların bir esterini ve Melaleuca alternifolia yağını içerir.
Patent TR-201905880-T4 (TR)
Title: Bir manyetik rezonans sistemi kullanılarak tanısal görüntülemedeki bir kontrast ajan konsantrasyonunun zaman profilinin önceden belirlenmesinin optimize edilmesine yönelik yöntem.
Inventor: MARTIN ROHRER
IPC: A61B5/00
Filed: 2016-05-10
Abstract: Bir damar konumundaki bir kontrast ajan konsantrasyonunun zaman profilinin önceden belirlenmesine ait bir yöntem, kontrast ajanın, yalnızca ilgi bölgesinde bulunan damara başlangıç doldurma fazı esnasında bir ilgi bölgesinin kontrast ajanı arttırılmış MRI bağlamında sağlanır. Yöntem, AW = W2 - W1 denklemine göre bir kontrast ajan bolus profilinin bir genişlemesinin kurulmasını içerir, burada W1, bir birinci damar konumundaki kontrast ajan bolus profilinin bir birinci genişliğidir ve W2, ilgi bölgesindeki bir ikinci damar konumunda bir kontrast ajan konsantrasyon profilinin bir ikinci genişliğidir. Genişleme, hastanın üçüncü bir damar konumunda en az bir kan akış özelliğine bağlı olan ve kontrast ajan profilinin genişlemesi ile ilişkili olan en az bir akış parametresinin belirlenmesiyle oluşturulur.
Patent TR-201911194-T4 (TR)
Title: Solunabilir bir ilaç.
Inventor: MUKUI DALVI
IPC: A61K9/00
Filed: 2014-11-21
Abstract: Buna göre, mevcut buluş, inhalasyona yönelik aşağıdakileri içeren bir solüsyon formülasyonu sağlar: sıvı fazda çözünmüş, hidrolize ve/veya solvolize karşı duyarlı bir fonksiyonel gruba sahip bir aktif içerik maddesi; ve sıvı fazda çözünmüş bir magnezyum veya kalsiyum tuzu. Formülasyon, özellikle pMDI'lar ve nebülizörlere yönelik uygundur.
Patent DE-10296749-T5 (DE)
Title: Gestaltung eines chemischen Bettes
Inventor: WIID CHRISTOFFEL FRANCOIS
IPC: A62B19/00
Filed: 2002-04-18
Abstract: Chemischer Reaktor für die Verwendung als, oder als ein Teil eines Respirationsapparates, wobei der Reaktor einen entgasenden Kanister zum Halten eines Bettes einer Partikelchemikalie, wobei der Kanister eine Umfangswand aufweist, die das Innere des Kanisters umschließt, und der Kanister einen Boden für das Innere des Kanisters aufweist,  einen luftdurchlässigen Bettträger, der die obere Oberfläche des Bodens zum Tragen eines Bettes aus Partikelreagenz in dem Innenraum des Kanisters auskleidet, wobei der Kanister wenigstens ein oberes Luftloch auf einem Niveau oberhalb des Bettträgers und wenigstens ein unteres Luftloch unterhalb des Trägers und durch den Boden aufweist; und  wenigstens eine luftdurchlässige Luft-Strömungsführung in dem Inneren des Kanisters zum Führen von Luftströmung zwischen dem Bettträger und dem oberen Luftloch des Kanisters und durch ein Bett aus Partikelchemikalie aufweist, das in dem Inneren des Kanisters an dem Bettträger des Kanisters getragen wird, wobei jede Luft-Strömungsführung von einer unteren Extremität derselben an oder benachbart...
Patent DE-10297292-T5 (DE)
Title: Verbesserung der Auslösung eines ESD-NMOS durch die Verwendung einer N-Unterschicht
Inventor: HULFACHOR RONALD BRETT
IPC: H01L31/062
Filed: 2002-10-18
Abstract: EDS-NMOS-Gerät, das einen Ausgangskontakt zu einer zu schüzrenden Schaltung definiert, wobei das Gerät aufweist:  eine p-Senke;  mindestens zwei in der p-Senke ausgeformte n-Strukturen;  eine n-Unterschicht in der Nähe der mindestens zwei n-Strukturen;  eine erste elektrische Verbindung vom Ausgangskontakt zur n-Unterstruktur und zur ersten der mindestens zwei n-Strukturen; und  eine zweite elektrische Verbindung von der zweiten der mindestens zwei n-Strukturen zur p-Senke und zu einem Masseanschluss.
Patent DE-10297418-T5 (DE)
Title: Maleinsäure-Derivat und härtbare Zusammensetzung, die dieses enthält
Inventor: CHOI WONMUN
IPC: C07D207/40
Filed: 2002-10-31
Abstract: Maleinsäure-Derivat,
erzeugt durch Reaktion einer Verbindung mit zumindest einer Thiol-Gruppe,
in einem Molekül
und einer Maleinsäure-Verbindung.
Patent DE-19983911-T5 (DE)
Title: Wachsamkeitsüberwachungssystem
Inventor: BURTON DAVID
IPC: B60K28/06
Filed: 1999-12-24
Abstract: Gerät zum Bestimmen eines Wachsamkeitszustandes eines Subjekts, beispielsweise eines Fahrers eines Fahrzeugs oder dgl.. Das Gerät umfaßt einen Einrichtung (1 bis 11) zum Überwachen einer oder mehrerer physiologischer Variablen, beispielsweise EEG-, EMG- und EOG-Signalen, die mit dem Subjekt verknüpft sind. Das Gerät umfaßt außerdem eine Einrichtung (13 bis 16) zum Herleiten von einer oder mehreren Variablen von Daten, die physiologische Zustände des Subjekts darstellen, die der oder jeder Variablen entsprechen, und eine Einrichtung (17), um von den Daten zu bestimmen, wenn der Wachsamkeitszustand des Subjekts sich unter einem vorher festgelegten Schwellenwert befindet. Das Gerät kann eine Einrichtung umfassen, um in die Steuerung des Fahrzeugs in dem Fall einzugreifen, daß die Wachsamkeit des Fahrers unter einem vorher festgelegten Schwellenwert ist.
Patent ES-2380005-T5 (ES)
Inventor: BRUSA FEDERICO
IPC: C08J9/32
Filed: 2005-09-08
Granted: 2016-08-01
Abstract: Foam products with densities between 0.10 and 0.28 are obtained by reacting at least one polyol with at least one isocyanate-prepolymer, in the presence of an amount of expandable microspheres within the range of 0.5 to 10% by weight on the weight of said polyol and an amount of expanding agent which is from 0.5 to 4,0 times the amount normally used for such polyol/isocyanate-prepolymer systems, and carrying out the polymer expansion step at a temperature which is sufficient to cause the substantially simultaneous expansion of the microspheres.